Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke

Abstract Background Apathy, or lack of motivation for goal-directed activities, contributes to reduced engagement in and benefit from rehabilitation, impeding recovery from stroke. Objective To examine the effects of strategy training, a behavioral intervention used to augment usual inpatient rehabi...

Full description

Saved in:
Bibliographic Details
Published inPM & R Vol. 7; no. 6; pp. 562 - 570
Main Authors Skidmore, Elizabeth R., PhD, OTR/L, Whyte, Ellen M., MD, Butters, Meryl A., PhD, Terhorst, Lauren, PhD, Reynolds, Charles F., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Apathy, or lack of motivation for goal-directed activities, contributes to reduced engagement in and benefit from rehabilitation, impeding recovery from stroke. Objective To examine the effects of strategy training, a behavioral intervention used to augment usual inpatient rehabilitation, on apathy symptoms over the first 6 months after stroke. Design Secondary analysis of randomized controlled trial. Setting Acute inpatient rehabilitation. Participants Participants with acute stroke who exhibited cognitive impairments (Quick Executive Interview Scores ≥3) and were admitted for inpatient rehabilitation were randomized to receive strategy training (n = 15, 1 session per day, 5 days per week, in addition to usual inpatient rehabilitation) or reflective listening (n = 15, same dose). Methods Strategy training sessions focused on participant-selected goals and participant-derived strategies to address these goals, using a global strategy training method (Goal-Plan-Do-Check). Reflective listening sessions focused on participant reflections on their rehabilitation goals and experiences, facilitated by open-ended questions and active listening skills (attending, following, and responding). Main Outcome Measures Trained raters blinded to group assignment administered the Apathy Evaluation Scale at study admission, 3 months, and 6 months. Data were analyzed with repeated-measures fixed-effects models. Results Participants in both groups had similar subsyndromal levels of apathy symptoms at study admission (strategy training, mean = 25.79, standard deviation = 7.62; reflective listening, mean = 25.18, standard deviation = 4.40). A significant group × time interaction (F2,28 = 3.61, P = .040) indicated that changes in apathy symptom levels differed between groups over time. The magnitude of group differences in change scores was large (d = −0.99, t28 = −2.64, P = .013) at month 3 and moderate to large (d = −0.70, t28 = −1.86, P = .073) at month 6. Conclusion Strategy training shows promise as an adjunct to usual rehabilitation for maintaining low levels of poststroke apathy.
Bibliography:Disclosures related to this publication: grants, National Institutes of Health (R01 HD074693), UPMC Rehabilitation Institute (P30 MH090333), University of Pittsburgh Office of Research Health Sciences (money to institution); consulting fee/honorarium, American Congress of Rehabilitation Medicine (money to author); support for travel to meeting for the study or other purposes, American Congress of Rehabilitation Medicine (money to author)
Disclosure: nothing to disclose
Disclosures outside this publication: board membership, American Association of Geriatric Psychiatry (money to author); employment, UPMC (money to author); royalties, licensed intellectual property (co‐inventor) Psychometric analysis of the Pittsburgh Sleep Quality Index (PSQI) (PRO10050447) (money to author); other, Bristol Meyers Squibb, Forrest Labs, Lily, Pfizer (provide pharmaceutical supplies for NIH‐sponsored work) (money to institution).
The pharmaceutical companies play no role in the design, analysis, or reporting of data in peer reviewed journals
Disclosures related to this publication: grant, NIH, Commonwealth of Pennsylvania, Center for Medicare and Medicaid Services (CMS), Patient Centered Outcomes Research Institute (PCORI), John A. Hartford Foundation, American Foundation for Suicide Prevention, Clinical and Translational Science Institute (CTSI), National Palliative Care Research Center (NPCRC) (money to institution); consulting fee/speaker honorarium, Medscape/WEB MD (money to author)
Disclosures outside this publication: consultancy, Boston University, RTI International, Rehabilitation Institute of Chicago (money to author); grants/grants pending, NIH (R01 HD055525, R21 HD071728, R03 HD073770, H133A120087, R01 NS084967, UL1 TR000005 UL1 RR024153) (money to institution); payment for lectures including service on speakers bureaus, St. Jude's Hospital, New England Rehabilitation Hospital, Rotman Research Institute, American Congress of Rehabilitation Medicine, University of Oklahoma (money to author); travel/accommodations/meeting expenses unrelated to activities listed, RTI International, Boston University, Rehabilitation Institute of Chicago, St. Jude's Hospital, New England Rehabilitation Hospital, Rotman Research Institute, American Congress of Rehabilitation Medicine, University of Oklahoma, Society for Neurotrauma (money to author)
Disclosures outside this publication: consultancy, GlaxoSmithKline (received remuneration for neuropsychological evaluation services) (money to author)
Disclosures outside this publication: grants/grants pending, NICHD/NCMRR (1R01HD055525) (money to institution)
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1934-1482
1934-1563
DOI:10.1016/j.pmrj.2014.12.010